Clinical Trial Update: The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating safety and efficacy of lurasidone with different initiation doses in Chinese patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• lurasidone (lurasidone)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED